Abbott Laboratories
ABT
$108.49
Share price
-0.19%
Change (1 day)
-8.69%
Change (1 year)
Categories
Abbott Laboratories (ABT), (founding name: Abbott Alkaloid Company) is a global pharmaceutical company with around 73,000 employees in 150 countries. Abbott was founded in 1888 by Wallace C. Abbott (1857-1921) and is headquartered in Abbott Park, a northern suburb of Chicago, Illinois.
Revenue for Abbott Laboratories (ABT)
Revenue in 2022 (TTM): $44.51 B
According to Abbott Laboratories's latest financial reports the company's current revenue (TTM) is $44.51 B. In 2021 the company made a revenue of $43.07 B an increase over the years 2020 revenue that were of $34.60 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Abbott Laboratories from 2001 to 2022
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2022 (TTM) | $44.51 B | 3.34% |
| 2021 | $43.07 B | 24.47% |
| 2020 | $34.60 B | 8.48% |
| 2019 | $31.90 B | 4.34% |
| 2018 | $30.57 B | 11.64% |
| 2017 | $27.39 B | 31.35% |
| 2016 | $20.85 B | 2.2% |
| 2015 | $20.40 B | -3.7% |
| 2014 | $21.18 B | -3.02% |
| 2013 | $21.84 B | -45.21% |
| 2012 | $39.87 B | 2.63% |
| 2011 | $38.85 B | 10.48% |
| 2010 | $35.16 B | 14.31% |
| 2009 | $30.76 B | 4.19% |
| 2008 | $29.52 B | 16.9% |
| 2007 | $25.25 B | 12.38% |
| 2006 | $22.47 B | 0.62% |
| 2005 | $22.33 B | 10.28% |
| 2004 | $20.25 B | 2.92% |
| 2003 | $19.68 B | 11.29% |
| 2002 | $17.68 B | 8.59% |
| 2001 | $16.28 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $94.88 B | 113.15% | 🇺🇸 USA |
 Novartis NVS | $51.74 B | 16.25% | 🇨🇭 Switzerland |
 Pfizer PFE | $92.36 B | 107.50% | 🇺🇸 USA |
 Medtronic MDT | $31.68 B | -28.82% | 🇮🇪 Ireland |
 Thermo Fisher Scientific TMO | $41.12 B | -7.62% | 🇺🇸 USA |
 Boston Scientific BSX | $12.16 B | -72.68% | 🇺🇸 USA |
 Hologic HOLX | $5.39 B | -87.89% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $46.46 B | 4.39% | 🇺🇸 USA |
 Astrazeneca AZN | $41.48 B | -6.80% | 🇬🇧 UK |
 GlaxoSmithKline GSK | $49.09 B | 10.30% | 🇬🇧 UK |